Medpace reports $716 million in Q3 revenue and approves $1 billion share repurchase
MEDP Medpace Holdings Inc
$669.20 +2.33%
View chart & analysis → - 1Medpace recorded Q3 2026 revenue of $716 million, an 8.5% increase year-over-year.
- 2Medpace's cash holdings increased to $705.3 million in Q3 2026.
- 3The board approved a $1 billion share repurchase program for Medpace.
So what's the key point?
Medpace saw its revenue grow by 8.5% compared to last year in the third quarter. The company's cash reserves increased, and it decided to buy back its own shares.
Source The Motley Fool · View original ↗
Nothing hidden: past picks and how they did against the S&P 500.